Transcranial Magnetic Stimulation for Low Back Pain
Not Applicable
Withdrawn
- Conditions
- Chronic Low Back Pain
- Interventions
- Device: Transcranial Magnetic Stimulation
- Registration Number
- NCT02070016
- Lead Sponsor
- Stanford University
- Brief Summary
The purpose of this study is to test whether non-invasive brain stimulation, such as Transcranial Magnetic Stimulation (TMS) may alleviate pain associated with various chronic pain conditions. We will test various methods of TMS to identify a treatment approach that may reduce the symptoms of chronic pain for the patient.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Age 18 or older
- Patient with Chronic Low Back Pain
- Meets minimum pain level criteria
- Ability to perform the experimental Task and Procedures
Read More
Exclusion Criteria
- MRI contraindication if an MRI exam is required per protocol
- TMS Contraindication
- History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher.
- Neurologic illness that would interfere with brain integrity
- Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher.
- Currently pregnant or planning to become pregnant.
- On going legal action or disability claim.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description TMS Parameter Condition 2 First Transcranial Magnetic Stimulation Application of Transcranial Magnetic Stimulation TMS Parameter Condition 1 first Transcranial Magnetic Stimulation Application of Transcranial Magnetic Stimulation
- Primary Outcome Measures
Name Time Method Change in Average Daily Pain Baseline Compared to each treatmeant series (at 4 weeks, 8 weeks, and 12 weeks) Compared to baseline pain report as provided by Visual Analogue Scale (VAS)
Change in Worst Daily Pain Baseline Compared to each treatment series (at 4 weeks, 8 weeks, and 12 weeks) As compared to baseline worst daily pain report provided on visual analogue scale (VAS)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Stanford University School of Medicine
🇺🇸Palo Alto, California, United States